Figure S3 from Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells
Vasyl Eisenberg,Shiran Hoogi,Erel Katzman,Nimrod Ben Haim,Raphaelle Zur-Toledano,Maria Radman,Yishai Reboh,Oranit Zadok,Iris Kamer,Jair Bar,Irit Sagi,Ayal Hendel,Cyrille J. Cohen
